GSK has announced positive headline outcomes from a Phase III trial of Blenrep with bortezomib and dexamethasone for multiple ...

The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...

The stocks all fell by more than 5% at the end of the day, except for Pfizer's stock, which only fell 2%, and stocks of the ...

The selection of vaccine sceptic Robert F Kennedy Jr by US President-elect Donald Trump to head the Department of Health and ...

Final results from the trials will be presented at upcoming medical conferences and will be submitted to regulators to support potential label updates, GSK added. Despite the nods from the FDA for ...

Elraglusib is undergoing investigation in an open-label, multicenter, phase 1/2 trial for the treatment of patients with ...

About the trial designs NCT06389487 is a phase IIIb open-label study to evaluate the non-inferiority of the immune response and to evaluate the safety of the GSK’s RSV vaccine in adults aged 18 ...

Things became litigious in 2017, when a Delaware court found that Teva's label for its generic encouraged doctors to use the drug to treat heart failure in a way that infringed GSK's RE40,000 ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...

Leading companies in the functional foods market are concentrating on creating innovative products, including new plant-based ingredients, to enhance their market position. Plant ingredients are ...

The label change also comes after GSK voluntarily withdrew another indication for Zejula as a late-line treatment for women with recurrent ovarian cancer, after it emerged that PARP inhibitors may ...